Conference item
A randomised trial of conventional care versus radioablation (stereotactic body radiotherapy) for extracranial oligometastases
- Abstract:
-
Studies indicate SBRT treatment of oligometastatic disease is associated with higher rates of local control with acceptably toxicity. A lack of randomised data in this area limits interpretation, preventing evaluation of the true benefit of adding SBRT to systemic therapy in this context. CORE investigates whether adding SBRT to standard therapy improves patient outcomes in common primary tumour sites where oligometastatic disease is encountered (NSCLC, breast and prostate). CORE aims to demo...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Accepted manuscript, pdf, 257.8KB)
-
- Publisher copy:
- 10.1016/j.clon.2018.02.061
Authors
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- Clinical Oncology Journal website
- Volume:
- 30
- Issue:
- 6
- Pages:
- e64-e64
- Host title:
- Clinical Oncology
- Publication date:
- 2018-04-30
- Acceptance date:
- 2018-02-09
- DOI:
- EISSN:
-
1433-2981
- ISSN:
-
0936-6555
- Source identifiers:
-
856254
Item Description
- Pubs id:
-
pubs:856254
- UUID:
-
uuid:86613c8e-cfc3-46f1-a74b-d2f408324fd6
- Local pid:
- pubs:856254
- Deposit date:
- 2018-10-30
Terms of use
- Copyright holder:
- Elsevier Ltd
- Copyright date:
- 2018
- Notes:
- Copyright © 2018 Published by Elsevier Ltd. This is the accepted manuscript version of the article. The final version is available online from Elsevier at: https://doi.org/10.1016/j.clon.2018.02.061
If you are the owner of this record, you can report an update to it here: Report update to this record